AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Future of Psychedelics
Amanda: I would argue that although the science risk and the technical risk of psychedelics is lower than in other areas of neuro maybe market risk maybe higher just because it's not a you know plug and play at least not today. We have we've looked at care delivery companies in the psychedelic space those that more have a telehealth approachThose that are training the providers that will be working with patients around psychedelics so have really looked across the landscape.